Literature DB >> 35021945

Design, synthesis, cytotoxic, and anti-inflammatory activities of some novel analogues of aloe-emodin isolated from the rhizomes of Rheum emodi.

G Dileep Kumar1,2, Bandi Siva1, K Ashwini1, J Vinod Kumar3, V Ramalingam1,2, A Sai Balaji2,3, K Suresh Babu1,2.   

Abstract

In connection with our continuous efforts in the synthesis of derivatives from major compounds isolated from traditional medicinal plants, in the present study we have attempted to synthesize the furan-conjugated aloe-emodin derivatives (5a-j) using a three-component reaction. The synthesized derivatives were assessed for anticancer activity against five different cancer cell lines using the in vitro MTT assay and the results showed that most of the derivatives are potent against cancer cells comparing with the control. Compounds 5a and 5e showed excellent activity against all the cancer cells with less than 12.5 µM and arrested the cell cycle at the G0/G1 phase in both CAL27 and SCC9 cells. Compound 5e induces the early apoptosis in CAL27 cells and compounds 5a and 5e induce early and late apoptosis, respectively, in SCC9 cells. Moreover, compounds 5b, 5c, 5i, and 5j showed excellent anti-inflammatory activity in LPS-stimulated RAW 264.7 cells by inhibiting IL-6 production. The molecular docking studies revealed that compound 5e has strong interaction with the CLK kinase and protein kinase II through hydrogen binding Asp325 and Lys290.

Entities:  

Keywords:  Rheum emodi; aloe-emodin; anti-inflammatory activity; anticancer; furan derivatives; tri-component reaction

Year:  2022        PMID: 35021945     DOI: 10.1080/14786419.2021.2024531

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  1 in total

1.  Piperazine tethered bergenin heterocyclic hybrids: design, synthesis, anticancer activity, and molecular docking studies.

Authors:  Banoth Venkateswara Rao; P Pavan Kumar; Vaikundamoorthy Ramalingam; G Karthik; Sai Balaji Andugulapati; K Suresh Babu
Journal:  RSC Med Chem       Date:  2022-05-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.